From first-hand experience, members of our Pharmaceutical Group understand the importance of patents, trademarks and trade secrets to pharmaceutical companies. Group members have conducted research at and represented pharmaceutical giants and startups alike. This means we understand the interaction of patents with a range of FDA issues such as patent term extensions, non-patent exclusivities, Orange Book listing requirements, Hatch-Waxman issues and ANDA (Abbreviated New Drug Application) litigation.
Our clients include global and emerging pharmaceutical companies such as Takeda, Vertex Pharmaceuticals and Viamet Pharmaceuticals, as well as prestigious academic and research institutions such as Harvard Medical School, Dana Farber Cancer Institute and Sloan Kettering. They appreciate our depth of experience as well as our attention to client service.
Members of our group have extensive experience in the pharma industry, having worked at such companies as Johnson & Johnson, Novartis and GlaxoSmithKline. We have worked as in-house legal counsel at companies including Cubist Pharmaceuticals and Amgen. As a result, we have an intimate understanding of the challenges in-house counsel face.
Working closely with our clients, we customize IP infrastructures that coordinate with and complement existing in-house protocols and systems. We create strategic plans for portfolios and adjust as IP and business needs dictate. We are forward-looking and proactive about filing strategies, always keeping in mind potential collaboration and licensing opportunities as well as future R&D efforts.